PSMA PET/CT Visualizes Prostate Cancer Recurrence Early, Impacts Radiation Therapy

Jeremie Calais, MD, and Nicholas G. Nickols, MD, PhD, at UCLA explain the potential benefits of PSMA PET/CT for prostate cancer patients with biochemical recurrence after radical prostatectomy. They point out that visualizing sites of prostate cancer recurrence accurately and early enough to guide therapy enables truly precision radiation therapy. The accompanying article is published in the February 2018 issue of The Journal of Nuclear Medicine.

Видео PSMA PET/CT Visualizes Prostate Cancer Recurrence Early, Impacts Radiation Therapy канала SNMChannel1